EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY-NC-ND 4.0

Exploiting the role of CSF NfL, CHIT1, and miR-181b as potential diagnostic and prognostic biomarkers for ALS

Delia Gagliardi, Mafalda Rizzuti, Pegah Masrori, Domenica Saccomanno, Roberto Del Bo, Luca Sali, Megi Meneri, Simone Scarcella, Ilaria Milone, Nicole Hersmus, Antonia Ratti, Nicola Ticozzi und 6 weitere

Journal of Neurology · 2024

DOI: 10.1007/s00415-024-12699-1 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Journal of Neurology, 2024. Verfasst von Delia Gagliardi und 17 weiteren Autor:innen. Beteiligte Einrichtung: Neurology Unit, Foundation IRCCS Cà Granda Ospedale Maggiore Policlinico, Milan, Italy. Hauptthemen laut MEDLINE: Amyotrophic Lateral Sclerosis, Neurofilament Proteins, Biomarkers, Hexosaminidases. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Ministero della Salute, VIB, KU Leuven, Fund for Scientific Research Flanders.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Amyotrophic lateral sclerosis (ALS) is a rare neurodegenerative disorder characterized by relentless and progressive loss of motor neurons. A molecular diagnosis, supported by the identification of specific biomarkers, might promote the definition of multiple biological subtypes of ALS, improving patient stratification and providing prognostic information. Here, we investigated the levels of neurofilament light chain (NfL), chitotriosidase (CHIT1) and microRNA-181b (miR-181b) in the cerebrospinal fluid (CSF) of ALS subjects (N = 210) as well as neurologically healthy and neurological disease controls (N = 218, including N = 74 with other neurodegenerative diseases) from a large European multicentric cohort, evaluating their specific or combined utility as diagnostic and prognostic biomarkers. NfL, CHIT1 and miR-181b all showed significantly higher levels in ALS subjects compared to controls, with NfL showing the most effective diagnostic performance. Importantly, all three biomarkers were increased compared to neurodegenerative disease controls and, specifically, to patients with Alzheimer's disease (AD; N = 44), with NfL and CHIT1 being also higher in ALS than in alpha-synucleinopathies (N = 22). Notably, ALS patients displayed increased CHIT1 levels despite having, compared to controls, a higher prevalence of a polymorphism lowering CHIT1 expression. While no relationship was found between CSF miR-181b and clinical measures in ALS (disease duration, functional disability, and disease progression rate), CSF NfL was the best independent predictor of disease progression and survival. This study deepens our knowledge of ALS biomarkers, highlighting the relative specificity of CHIT1 for ALS among neurodegenerative diseases and appraising the potential diagnostic utility of CSF miR-181b.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Amyotrophic Lateral SclerosisNeurofilament ProteinsBiomarkersHexosaminidasesMicroRNAsHumansFemaleMaleMiddle AgedAgedPrognosisAdultCohort StudiesDisease ProgressionAged, 80 and over

Stichwörter der Autor:innen

ALSBiomarkerCHIT1CSFMiR-181bNfL

Substanzen

neurofilament protein LchitotriosidaseNeurofilament ProteinsBiomarkersHexosaminidasesMicroRNAsMIrn181 microRNA, human

Autor:innen und Institutionen

  • Neurology Unit, Foundation IRCCS Cà Granda Ospedale Maggiore Policlinico, Milan, Italy.
  • Department of Neurosciences, Laboratory of Neurobiology, University of Leuven (KU Leuven), Louvain, Belgium.
  • Neurology Department, University Hospitals Leuven, Louvain, Belgium.
  • Department of Pathophysiology and Transplantation, Dino Ferrari Center, Università degli Studi di Milano, Milan, Italy.
  • Department of Neurology and Laboratory of Neuroscience, IRCCS Istituto Auxologico Italiano, Milan, Italy.
  • Department of Medical Biotechnology and Translational Medicine, Università degli Studi di Milano, Milan, Italy.

Förderung

  • Ministero della Salute
  • VIB, KU Leuven
  • Fund for Scientific Research Flanders
  • TBM grant from FWO-Vlaanderen
  • FWO-Vlaanderen

Zitieren

APA

Gagliardi, D., Rizzuti, M., Masrori, P., Saccomanno, D., Del Bo, R., Sali, L., Meneri, M., Scarcella, S., Milone, I., Hersmus, N., Ratti, A., Ticozzi, N., Silani, V., Poesen, K., Van Damme, P., Comi, G. P., Corti, S., & Verde, F. (2024). Exploiting the role of CSF NfL, CHIT1, and miR-181b as potential diagnostic and prognostic biomarkers for ALS. Journal of Neurology. https://doi.org/10.1007/s00415-024-12699-1

Vancouver

Gagliardi D, Rizzuti M, Masrori P, Saccomanno D, Del Bo R, Sali L, et al. Exploiting the role of CSF NfL, CHIT1, and miR-181b as potential diagnostic and prognostic biomarkers for ALS. Journal of Neurology. 2024. doi:10.1007/s00415-024-12699-1

BibTeX
@article{Gagliardi2024,
  author = {Gagliardi, Delia and Rizzuti, Mafalda and Masrori, Pegah and Saccomanno, Domenica and Del Bo, Roberto and Sali, Luca and Meneri, Megi and Scarcella, Simone and Milone, Ilaria and Hersmus, Nicole and Ratti, Antonia and Ticozzi, Nicola and Silani, Vincenzo and Poesen, Koen and Van Damme, Philip and Comi, Giacomo Pietro and Corti, Stefania and Verde, Federico},
  title = {Exploiting the role of CSF NfL, CHIT1, and miR-181b as potential diagnostic and prognostic biomarkers for ALS},
  journal = {Journal of Neurology},
  year = {2024},
  doi = {10.1007/s00415-024-12699-1}
}
Kostenlos starten →